Life and death in otolaryngology: Mechanisms of apoptosis and its role in the pathology and treatment of disease

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 7, 1999, Pages 729-737

  Mostafapour, Sam P ^a,b   Hockenbery, David M ^a,b   Rubel, Edwin W ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CASPASE; CYTOCHROME C; DNA; FAS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; AUDITORY SYSTEM; AUTOIMMUNE DISEASE; CELL DEATH; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; MITOCHONDRION; NEOPLASM; NONHUMAN; OLFACTORY EPITHELIUM; ONCOGENE; REVIEW; SURVIVAL; TUMOR SUPPRESSOR GENE; VESTIBULAR SYSTEM;

EID: 0032808409     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.7.729     Document Type: Review

References (105)

1. Greenfield LJ. Surgery, Scientific Principles and Practice. Philadelphia, Pa: JB Lippincott: 1993:xv.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
3. Gleich LL, Li YQ, Biddinger PW, et al. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer. Laryngoscope. 1996;106:1378-1381.
4. Brennan JA, Mao L, Hruban RH et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:429-435.
5. Zhang LF, Hemminki K, Szyfter K, Szyfter W, Soderkvist P. p53 Mutations in larynx cancer. Carcinogenesis. 1994;15:2949-2951.
6. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci U S A. 1993; 90:10914-10921.
7. Yuan J. Evolutionary conservation of a genetic pathway of programmed cell death. J Cell Biochem. 1996;60:4-11.
8. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 1994;76:665-676.
9. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science. 1992;258:1955-1957.
10. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
11. Golstein P. Controlling cell death. Science. 1997;275:1081-1082.
12. Hetts SW. To die or not to die: an overview of apoptosis and its role in disease. JAMA. 1998;279:300-307.
13. Reed JC. Cytochrome c: can't live with it - can't live without it. Cell. 1997;91: 559-662.
14. Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol. 1991;7:663-698.
15. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature [letter]. Cell. 1996;87:171.
16. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 1993;75:653-660.
17. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell. 1993;75:641-652.
18. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90:405-413.
19. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science. 1997;275: 1122-1126.
20. Hockenbery DM. bcl-2 in cancer, development and apoptosis. J Cell Sci Suppl. 1994;18:51-55.
21. Bakhshi A, Jensen JP, Goldman P et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985;41:899-906.
22. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985;82:7439-7443.
23. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1097-1099.
24. Seto M, Jaeger U, Hockett RD et al. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 1988;7:123-131.
25. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335: 440-442.
26. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 1991; 349:254-256.
27. McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989;57:79-88.
28. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 1993;75:229-240.
29. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
30. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 1995;80:285-291.
31. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74: 597-608.
32. Park JR, Hockenbery DM. BCL-2, a novel regulator of apoptosis. J Cell Biochem. 1996;60:12-17.
33. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
34. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129-1132.
35. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
36. Zamzami N, Marchetti P, Castedo M, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 1995;181:1661-1672.
37. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: back to the future. FEBS Lett. 1996;396:7-13.
38. Zamzami N, Marchetti P, Castedo M, et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 1996;384:53-57.
39. Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 1996;381:335-341.
40. Minn AJ, Velez P, Schendel SL, et al. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 1997;385:353-357.
41. Antonsson B, Conti F, Ciavatta A, et al. Inhibition of Bax channel-forming activity by Bcl-2. Science. 1997;277:370-372.
42. Marchetti P, Hirsch T, Zamzami N, et al. Mitochondrial permeability transition triggers lymphocyte apoptosis. J Immunol. 1996;157:4830-4836.
43. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219-228.
44. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 1995;18:58-60.
45. Budd SL, Nicholls DG. A reevaluation of the role of mitochondria in neuronal Ca2+ homeostasis. J Neurochem. 1996;66:403-411.
46. Herrington J, Park YB, Babcock DF, Hille B. Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells. Neuron. 1996; 16:219-228.
47. Mostafapour SP, Lachica EA, Rubel EW. Mitochondrial regulation of calcium in the avian cochlear nucleus. J Neurophysiol. 1997;78:1928-1934.
48. Werth JL, Thayer SA. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci. 1994;14:348-356.
49. Mann MC, Fernandez A, Bick RJ, et al. Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene. 1996;12: 2259-2266.
50. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A. 1996;93:9893-9898.
51. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-1312.
52. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 1996;85:817-827.
53. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998; 281:1305-1308.
54. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science. 1991;253:49-53.
55. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453-456.
56. Hooper ML. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl. 1994:18:13-17.
57. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 Is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847-849.
58. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 1993;362:849-852.
59. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994;78: 539-542.
60. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model lor p53-induced apoptosis. Nature. 1997;389:300-305.
61. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA, Tetu B. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinico-pathologic and immunohistochemical study. J Clin Oncol. 1997;15:1030-1038.
62. Clayman GL, Liu TJ, Overholt SM, et al. Sene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/ CIP1 (p21). Arch Otolaryngol Head Neck Surg. 1996;122:489-493.
63. Purves D, Lichtman JW. Principles of Neural Development. Sunderland, Mass: Sinauer Associates Inc; 1985.
64. Born DE, Rubel EW. Afferent influences on brain stem auditory nuclei of the chicken: neuron number and size following cochlea removal. J Comp Neurol. 1985;231:435-445.
65. Hashisaki GT, Rubel EW. Effects of unilateral cochlea removal on anteroventral cochlear nucleus neurons in developing gerbils. J Comp Neurol. 1989;283:5-73.
66. Moore JK, Niparko JK, Perazzo LM, Miller MR, Linthicum FH. Effect of adult-onset deafness on the human central auditory system. Ann Otol Rhinol Laryngol. 1997;106:385-390.
67. Lachica EL, Zirpel L, Rubel EW. Intracellular mechanisms involved in the afferent regulation of neurons in the avian cochlear nucleus. In: Auditory System Plasticity and Regeneration. New York, NY: Thieme-Stratton Inc; 1996:333-353.
68. Rubel EW, Hyson RL, Durham D. Afferent regulation of neurons in the brain stem auditory system. J Neurobiol. 1990;21:169-196.
69. Hartlage-Rübsamen M, Rubel EW. Influence of mitochondrial protein synthesis inhibition on deafferentation-induced ultrastructural changes in the nucleus magnocellularis of developing chicks. J Comp Neurol. 1996;371:448-460.
70. Garden GA, Canady KS, Lurie DI, Bothwell M, Rubel EW. A biphasic change in ribosomal conformation during transneuronal degeneration is altered by inhibition of mitochondrial, but not cytoplasmic protein synthesis. J Neurosci. 1994; 14:1994-2008.
71. Hyde GE, Durham D. Rapid increase in mitochondrial volume in nucleus magnocellularis neurons following cochlea removal. J Comp Neurol. 1994;339: 27-48.
72. Hyde GE, Durham D. Cytochrome oxidase response to cochlea removal in chicken auditory brainstem neurons. J Comp Neurol. 1990;297:329-339.
73. Zirpel L, Lachica EA, Lippe WR. Deafferentation increases the intracellular calcium of cochlear nucleus neurons in the embryonic chick. J Neurophysiol. 1995; 74:1355-1357.
74. Hyde GE, Durham D. Increased deafferentation-induced cell death in chick brainstem auditory neurons following blockade of mitochondrial protein synthesis with chloramphenicol. J Neurosci. 1994;14:291-300.
75. Budd SL, Nicholls DG. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurochem. 1996;67: 2282-2291.
76. Schinder AJ, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci. 1996;16:6125-6133.
77. Jacobs HT. Mitochondrial deafness. Ann Med. 1997;29:483-491.
78. Suomalainen A. Mitochondrial DNA and disease. Ann Med. 1997;29:235-246.
79. Trune DR. Influence of neonatal cochlear removal on the development of mouse cochlear nucleus, I: number, size, and density of its neurons. J Comp Neurol. 1982;209:409-424.
80. Trune DR. Influence of neonatal cochlear removal on the development of mouse cochlear nucleus, II: dendritic morphometry of its neurons. J Comp Neurol. 1982; 209:425-434.
81. Mostafapour SP, Cochran SL, Rubel EW. Afferent regulation of neuronal survival in the VCN of developing mice. Assoc Res Otolaryngol Abs. 1998;851.
82. Tierney TS, Russell FA, Moore DR. Susceptibility of developing cochlear nucleus neurons to deafferentation-induced death abruptly ends just before the onset of hearing. J Comp Neurol. 1997;378:295-306.
83. Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol. 1997;34:9-19.
84. el-Deiry WS. Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr Opin Oncol. 1997;9:79-87.
85. Tu Y, Xu FH, Liu J, et al. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. Blood. 1996;88:1805-1812.
86. Ellis PA, Smith IE, Detre S, et al. Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res Treat. 1998;48:107-116.
87. Whisler LC, Wood NB, Caldarelli DD, et al. Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope. 1998;108:630-638.
88. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1996;122:627-632.
89. Prives C. Signaling to p53: breaking the MDM-p53 circuit. Cell. 1998;95:5-8.
90. Steele RJ, Thompson AM, Hall PA, Lane DP. The p53 tumour suppressor gene. Br J Surg. 1998;85:1460-1467.
91. Salo A, Servomaa K, Kiuru A, et al. The bcl-2 gene status of human head and neck cancer cell lines. Acta Otolaryngol Suppl (Stockh). 1997;529:233-236.
92. Mitsiades N, Poulaki V, Kotoula V, et al. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1998;83:2199-203.
93. Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, Mirakian R. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. J Pathol. 1997;182:138-144.
94. Kawakami A, Eguchi K, Matsuoka N, et al. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clin Exp Immunol. 1997;110:434-439.
95. Lorenz HM, Grunke M, Hieronymus T, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum. 1997; 40:306-317.
96. Graziadei GA, Graziadei PP. Neurogenesis and neuron regeneration in the olfactory system of mammals, II: degeneration and reconstitution of the olfactory sensory neurons after axotomy. J Neurocytol. 1979;8:197-213.
97. Graziadei PP, Graziadei GA. Neurogenesis and neuron regeneration in the olfactory system of mammals, I: morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J Neurocytol. 1979; 8:1-18.
98. Calof AL, Hagiwara N, Holcomb JD, Mumm JS, Shou J. Neurogenesis and cell death in olfactory epithelium. J Neurobiol. 1996;30:67-81.
99. Brunjes PC. Unilateral naris closure and olfactory system development. Brain Res Brain Res Rev. 1994;19:146-160.
100. Nishizaki K, Anniko M, Orita Y, Karita K, Masuda Y, Yoshino T. Programmed cell death in the developing epithelium of the mouse inner ear. Acta Otolaryngol (Stockh). 1998;118:96-100.
101. Ishii N, Wanaka A, Ohno K, et al. Localization of bcl-2, bax, and bcl-x mRNAs in the developing inner ear of the mouse. Brain Res. 1996;726:123-128.
102. Fekete DM, Homburger SA, Waring MT, Riedl AE, Garcia LF. Involvement of programmed cell death in morphogenesis of the vertebrate inner ear. Development. 1997;124:2451-2461.
103. Jokay I, Soos G, Repassy G, Dezso B. Apoptosis in the human inner ear. Detection by in situ end-labeling of fragmented DNA and correlation with other markers. Hear Res. 1998;117:131-139.
104. Lang H, Liu C. Apoptosis and hair cell degeneration in the vestibular sensory epithelia of the guinea pig following a gentamicin insult. Hear Res. 1997;111: 177-184.
105. Li L, Nevill G, Forge A. Two modes of hair cell loss from the vestibular sensory epithelia of the guinea pig inner ear. J Comp Neurol. 1995;355:405-417.